Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
pretty smart. use a PR to report some contracts and mention the accretive acquisistion still in the works.
hopefully they don't end up extending the timeline on that. also hoping they don't issue more than around 2M shares
ONCS - SA author w/ 1678 followers calling for 50% near-term runup in ONCS.
OncoSec Medical: The Microcap Biotech With The Billion Dollar Immuno-Oncology Solution
http://seekingalpha.com/article/3604486-oncosec-medical-the-microcap-biotech-with-the-billion-dollar-immuno-oncology-solution
Trading with a market cap of only ~$60M, over $30M in cash, several Phase 2 clinical trials underway, impressive clinical data and the potential to revolutionize immuno-oncology treatment, I believe OncoSec is extremely undervalued and a prime acquisition target for a pharma company looking to optimize PD-1 inhibitor or other compounds efficacy. Look for the stock to rebound back to ~$100M market cap in the next couple months as investors become more familiar with the stock.
AVXL Announces Uplisting to NASDAQ
http://finance.yahoo.com/news/anavex-announces-uplisting-nasdaq-110000455.html
CETX Could be an interesting week for CETX coming up, with "highly accretive " acquisition supposedly closing by Nov.
A $2.4M boost to EBITDA would do amazing things to EPS, so long as they don't have to dilute too much to get that EBITDA.
Would also expect an update on their India renewable energy JV before too long (been about 2 months since PR).
Third potential catalyst would be earnings in mid-Nov. Not expecting big gains there since comps aren't especially easy, and could contain some uplist one-time costs....but hopefully increasing revenue trend is still intact.
CNTF - pushing up against 50ma, with activists carrying spears, value funds buying, and china sentiment improving. Sounds like a decent story for a push to $1+
YECO - seems like the better the news, the more muted the response. Gonna take the right environment for this to jam, but Q4 is the time for that environment.
http://finance.yahoo.com/news/yulong-signs-agreements-aimed-allowing-120000164.html
re: PRSN - today's PR reads strikingly well. I'm surprised this isn't over $1 with 10M share volume today...lesser catalysts have done that.
I mean "complete necrosis" and "complete response" are not terms that are thrown about lightly in the onco arena. And toss in 92% and 80% for good measure (albeit small sample sizes)
Not inclined to sell anytime soon, but the content of the PR likely hasn't gone mainstream yet...maybe we get a delayed reaction.
http://finance.yahoo.com/news/perseon-announces-data-microthermx-r-131500888.html
PRSN - nice update ash. I like the r/r here.
LBIO - looks like there's a lockup expiration on 8/26
http://www.nasdaq.com/markets/spos/company/lion-biotechnologies-inc-768877-77061
KBIO - FDA news just out: FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia
Reverse splitter that hasn't had a run yet, now has catalyst
LBIO started some in 8.50s for a swing. not entirely comfortable with how it's trading, so pretty tight leash on it. reward/risk seems favorable for a run back over 9
NK/FATE/FBIO - Looks like the $NK IPO is gonna be a hot one, accelerated, and oversubscribed. Others in the Natural Killers space might get some attention, such as FATE and FBIO.
CBAY offering.
OPGN Merck invests $6M into OPGN @ $4.40; stock at 3.99. OPGN then buys AdvanDX, in whom Merck is also an investor.
Sounds like MRK wants MRSA exposure.
Deal w/ MRK:
http://finance.yahoo.com/news/opgen-closes-6-million-financing-130500363.html
Acquisition of AdvanDX:
http://finance.yahoo.com/news/opgen-acquire-advandx-inc-130113225.html
Yesterday's news with Fluidigm:
http://finance.yahoo.com/news/fluidigm-opgen-enter-strategic-agreement-160000564.html
2.9M share IPO back in May was a dog, but newsflow right now is good.
ITUS/D approved for nasdaq listing
https://finance.yahoo.com/news/itus-announces-uplisting-nasdaq-200100836.html
(whoops...mike beat me to it)
$BVXV $15PT out from Aegis just now. Stock at $5.15 Phase2 results on "holy grail" universal flu vaccine due any day
CTEI-->CETX NASDAQ 6/25
https://finance.yahoo.com/news/cemtrex-inc-announces-uplisting-nasdaq-125500179.html
DHXM NAS Global mkt approval for listing (also on Toronto)
https://finance.yahoo.com/news/dhx-media-commence-trading-nasdaq-185800081.html
BVXV - Sheff, any thoughts on BVXV? Universal flu vaccine.
3 potential catalysts upcoming:
1) Quiet period expires 6/22; could get some analyst coverage
2) Ph3 manufacturing partner announcement coming (per prior PRs)
3) Ph2 data announcement coming by the end of Q2, or 6/30. Previous trial data has been good
Some interesting potential catalysts in the wings:
1) Quiet period expires 6/22; could get some analyst coverage
2) Ph3 manufacturing partner announcement coming
3) Ph2 data announcement coming by the end of Q2, or 6/30. Previous trial data has been good
Exclusive: IBM looking at adopting bitcoin technology for major currencies
Could provide a nice psychological boost for MGT at a time when it's struggling.
https://finance.yahoo.com/news/exclusive-ibm-looking-adopting-bitcoin-202623410.html
OCAT and LBIO uplisted today
GURE - making accretive chinese antibiotics co. acquisition...expects $15M in net income from it in 2015
https://finance.yahoo.com/news/gulf-resources-accelerates-transformation-enters-133000252.html
GBGD award over double mkt cap
International Arbitration Issues Final Award, Granting Over $10.8 Million Damages and Additional Relief in Favor of Global Gold Against Caldera Resources Related to Marjan Gold Mine in Armenia
The November 10, 2014 Final Award resolved all other outstanding issues with the following specific findings and rulings requiring Caldera to:
turn over to Global Gold at its offices in Rye, New York all books, records, contracts, communications, and property related in any way to the Marjan property in Armenia and the Marjan Mining Company, including specifically the Armenian Marjan Mining Company seal, and shall pay Global Gold $50,000 plus $250 per day for every day following issuance of this Final Award that such materials are not delivered;
turn over to Global Gold at its offices in Rye, New York communications Caldera and/or Mr. Mavridis has had with third parties concerning Global Gold its officers, agents, directors and business...Without limitation, the following shall also be turned over to Global Gold: all direct and indirect (for example through a translator or agent) communications with the following individuals and organizations: Azat Vartanian, Petros Vartanian, ..., Joseph Borkowski, Jeffrey Marvin,... Prem Premraj..., Rasia FZE, Johan Ulander, Ecolur,... Tom Prutzman, ..., Stockhouse, Investor's Hub, shareholders of Global Gold, and any governmental or regulatory authorities-- Caldera shall pay Global Gold $100 per day for every day following issuance of this Final Award that such materials are not delivered;
issue a press release correcting the April 30, 2013 Caldera release ...stating that the original release is retracted with all property books and records (including all exploration data) related to the Marjan property transferred to Global Gold and that neither Caldera nor its successors retain rights to the Marjan mine in Armenia and shall pay Global Gold $50,000 plus $100 per day for every day following issuance of this Final Award that such correcting release is not issued;
Caldera did not spend the minimum $1 million threshold necessary to be eligible for an NSR Royalty interest and therefore Caldera has no NSR Royalty or any other interest in the Marjan property;
the $150,000 which Caldera paid to Global Gold was not pursuant to the JV Agreement (which did not become effective) but pursuant to the December 2009 Agreement therefore Global Gold is not obligated to make any payments to Caldera;
pay Global Gold $115,000 for Caldera's refusal to turn over 500,000 shares of stock in 2010;
pay Global Gold $3,174,209 for Caldera's failure to make agreed payments to Global Gold;
pay Global Gold $577,174 for legacy governmental liabilities concerning the Marjan property and shall indemnify and hold Global Gold harmless (including attorney fees) from any governmental claims or liabilities associated with the time they control the seal of the Marjan Mining Company;
pay Global Gold $967,345 for violating Paragraph (1) of the Final Partial Award requiring turnover of property and [for] interference in Global Gold's development of Marjan and shall relinquish the portions of the Marjan West license which overlap or in any way impinge on Marjan;
Caldera is liable for defamation and tortious interference with contractual and business relations with regard to Global Gold and its related personnel and so shall (i) pay Global Gold $3 million in compensatory damages..., (ii) pay Global Gold $1 million in punitive or exemplary damages..., (iii) remove all the materials and websites controlled in any way by them which were admitted as exhibits on defamatory publications in this case from the internet and other locations, (iv) remove and be permanently enjoined from using Global Gold's trading symbol without permission; (v) not share those materials with others or arrange to have them posted anonymously or otherwise- (vi) independently, ... Global Gold and those who have been named by Caldera and Bill Mavridis in the admitted exhibits on defamatory publications as well as their attorneys [are granted] the authority to contact internet service providers, search engine firms, social media sites, stock discussion boards (including but not limited to Google, Yahoo, Facebook, Twitter, Stockhouse, Investor's Hub and Bing) to use this Final Award to remove the material as defamatory;
for the breaches of the Confidentiality Stipulations and Orders in this case, ...all publications of "confidential" or attorney eyes only material [shall] be removed from the internet and any other locations and that their substance not be republished and ...Global Gold and its attorneys [are granted] the authority to contact internet service providers, search engine firms, social media sites, stock discussions board (including but not limited to Google, Yahoo, Facebook, Twitter, Stockhouse, Investor's Hub and Bing) to use this Final Award to remove the material-- Caldera shall pay Global Gold for $100 per day every day that persons associated with Caldera remain in violation of the Confidentiality Stipulation and Order following the issuance of this Final Award including for each day until full disclosure of all emails and other communications with third parties that the information was shared with or discussed;
pay $1,822,416 for attorney fees and costs;
reimburse Global Gold $88,269 paid to the arbitration association and for the compensation and expenses of the arbitrator;
GV - traders liking the backlog and fwd look
NNAN = LAKE/VSR junior. Will be interesting to see if it has any SIMH in it, with multiday potential. Mkt cap < $2M here
CTSO **Fresh Ebola Play**
Ebola discussed in earnings PR and in presentation:
Earnings PR: http://finance.yahoo.com/news/preliminary-q3-2014-report-cytosorbents-104500370.html
Presentation (see pgs. 23 & 24): http://www.cytosorbents.com/pdf/CytoSorbents_Q2_2014_Presentation.pdf
MYRY - who wouldn't want an ebola tracker?
Myriad Interactive Media Inc. (MYRY) to develop state of the art Ebola tracking system
Toronto, Ontario - Las Vegas, Nevada / ACCESSWIRE / October 15, 2014 / Myriad Interactive Media Inc. (OTCQB: MYRY),(XNG.BE), (XNG.F), a global interactive media and development company has been retained by Mouse LLC to develop a new Ebola tracking system.
"We are pleased to announce that we have been retained by Mouse, LLC to develop a scalable system to track EBOLA. The current Ebola outbreak continues to see new cases of infection and subsequent deaths which have been alarming to say the least.", said Myriad CEO Derek Ivany. "Now that the disease has penetrated America and other Western countries we see the need to build a system that provides real-time notifications to citizens and keeps them updated with what is going on with the disease," continued Ivany.
NNLX ebola news today +65% but off highs
NanoLogix Technology Being Configured For Rapid Ebola Virus Detection
http://finance.yahoo.com/news/nanologix-technology-being-configured-rapid-133000710.html
MMRF was the only otc with ebola PR today ( hospital solution ) and only closed up 27%
MMRF Ebola news from earlier:
Two nationally syndicated television commercials, including retailer tags, can also be seen at
MMRF Ebola news today:
http://finance.yahoo.com/news/mymedicalrecords-launches-television-advertising-interoperable-121500673.html
According to Robert H. Lorsch, MMRGlobal CEO, "At this time, when hospitals rely on diagnostic decisions by computer through an Electronic Medical Records ("EMR") system, it's more important than ever for the patient to be in control of their care. EMRs are being installed in hospitals and medical offices nationwide. Many healthcare professionals rely on them for diagnostic decisions, often removing the human care element by looking at a screen instead of the patient. These systems have cost taxpayers more than 28 billion dollars through reimbursements mandated under the HITECH Act. The impact of this shift in the care of a patient is scary. Even after Ebola patient zero told an emergency room intake person that he had just returned from Liberia, the EMR system on site sent the patient home to be treated for flu. Had the patient had a PHR that the emergency room could have looked at, doctors would have immediately seen that he had traveled from Africa, and the outcome might have been very different."
GOVX interesting new Ebola OTC
http://geovax.com/component/easyblog/entry/2014/10/02/geovax-announces-initiation-of-ebola-vaccine-development-program.html?Itemid=101
GeoVax Labs, Inc. : GeoVax Announces Initiation of Ebola Vaccine Development Program
BSPM HepB & Liver cancer news:
Worth a radar considering china crack on stocks at this price range
https://finance.yahoo.com/news/biostar-pharmaceuticals-inc-files-prc-120000327.html
XIANYANG, China, Sept. 18, 2014 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or the "Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, announced today it has filed PRC national invention and creation patent for the pharmaceutical and preparation method of its new developed product, Oleanolic Acid Injection, which designed to treat Hepatitis B and liver cancer. The application passed the preliminary examination of the PRC State Intellectual Property Bureau and was accepted for review; the application acceptance number is 201410182757.7.
The filed patent is for the pharmaceutical and preparation method developed by the Company's R&D team, together with the experts of Shaanxi University of Chinese Medicine after nearly 2 years of research and development effort. It is one of drug development efforts by the Company in combating Hepatitis B and liver cancer and is currently under pharmacological research.
Mr. Ronghua Wang, Chairman of the Company commented: "The filing and acceptance for review of the invention patent application indicates that the Company had made considerable progress in developing its Oleanolic Acid Injection. This promises to establish technical foundation for the product's research and development and future expansion. The Company will continue to increase investment in its research and development efforts to generate effective drugs for the PRC markets."
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com.
LLLI Asia contract news
Lamperd Less Lethal, Inc. Opens Sales in Asia
SARNIA, ON--(Marketwired - Sep 9, 2014) - Lamperd Less Lethal (PINKSHEETS: LLLI) made its first foray into Asia receiving a product order from a major South Korean manufacturer. The manufacturer has expressed interest in purchasing additional products in a timely manner. We look forward to a long and beneficial association.
LLLI is working diligently to secure orders from several areas around the world where civil unrest festers just below the surface stirred by militant factions of various country's population. The governments of these countries are seeking non-lethal alternatives for crowd control during protests and civil disturbances. Our streaming audio and video WIFI Body Camera worn by police and military personnel continues to gain world wide attention.
https://finance.yahoo.com/news/lamperd-less-lethal-inc-opens-123000411.html
LLLI Asia contract news
Lamperd Less Lethal, Inc. Opens Sales in Asia
SARNIA, ON--(Marketwired - Sep 9, 2014) - Lamperd Less Lethal (PINKSHEETS: LLLI) made its first foray into Asia receiving a product order from a major South Korean manufacturer. The manufacturer has expressed interest in purchasing additional products in a timely manner. We look forward to a long and beneficial association.
LLLI is working diligently to secure orders from several areas around the world where civil unrest festers just below the surface stirred by militant factions of various country's population. The governments of these countries are seeking non-lethal alternatives for crowd control during protests and civil disturbances. Our streaming audio and video WIFI Body Camera worn by police and military personnel continues to gain world wide attention.
https://finance.yahoo.com/news/lamperd-less-lethal-inc-opens-123000411.html
welcome oct! now all we need is knowledge-is-queen
love it here harry!
dade - i'm just trying to help explain its movement. not trying to make a case for whether to buy/sell long-term/short-term...i'll leave that to you
GV - more evidence of their involvement w/ TSLA. Permits
http://tinyurl.com/pjofg25